Wealth Effects LLC Abb Vie Inc. Transaction History

Wealth Effects LLC

$255 Million
Q3 2024

A detailed history of Wealth Effects LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Effects LLC holds 12,859 shares of ABBV stock, worth $2.26 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

12,859

Previous 12,881 0.17%

Holding current value

$2.26 Million

Previous $2.21 Million 14.94%

% of portfolio

1.0%

Previous 0.91%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$163.84 - $199.33 $3,604 - $4,385	-22 Reduced 0.17%	12,859 $2.54 Million
Q2 2024 Aug 02, 2024	BUY	$154.79 - $180.76 $181,568 - $212,031	1,173 Added 10.02%	12,881 $2.21 Million
Q1 2024 Apr 22, 2024	SELL	$159.82 - $182.1 $66,005 - $75,207	-413 Reduced 3.41%	11,708 $2.13 Million
Q4 2023 Jan 29, 2024	BUY	$137.6 - $154.97 $19,264 - $21,695	140 Added 1.17%	12,121 $1.88 Million
Q3 2023 Oct 16, 2023	SELL	$133.59 - $154.65 $6,545 - $7,577	-49 Reduced 0.41%	11,981 $1.79 Million
Q2 2023 Jul 18, 2023	SELL	$132.51 - $164.9 $80,831 - $100,589	-610 Reduced 4.83%	12,030 $1.62 Million
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $270,276 - $311,263	-1,869 Reduced 12.88%	12,640 $2.01 Million
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $4,010 - $4,810	-29 Reduced 0.2%	14,509 $2.35 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $40,263 - $46,179	300 Added 2.11%	14,538 $1.95 Million
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $67,571 - $85,905	491 Added 3.57%	14,238 $2.18 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $58,863 - $73,032	-446 Reduced 3.14%	13,747 $2.23 Million
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $1.52 Million - $1.93 Million	14,193 New	14,193 $1.92 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Effects LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Effects LLC with notifications on news.

Account

Wealth Effects LLC Abb Vie Inc. Transaction History